Elevance Health in the news

Elevance Health Inc. stock performed well, outdoing its competitors on a strong trading day.

Elevance Health's recent news includes upcoming Q3 results discussion, advancements in Medicare Advantage plans, stabilized margins, and its status as a defensive income stock.

Barclays raised Elevance Health's price target to $469 and kept an Overweight rating.

Elevance Health Inc. stock surpassed competitors in trading.

Elevance Health will release third-quarter results and hold a conference call on October 21, with the document also discussing sentiment analysis and balance of points metrics.

Elevance Health's stock appears undervalued based on its P/E ratio compared to its industry and peers, despite a 12.4% gain over the last year, with growth driven by Medicare Advantage and digital platforms.

Elevance Health (ELV) has outperformed its sector and industry year-to-date, showing positive analyst sentiment and a Zacks Rank of #2 (Buy).

Elevance Health will no longer pay hospital rates for specific off-campus clinic care, aiming to reduce facility fees and lower healthcare costs.

Elevance Health announced its 2027 Medicare Advantage plans.

Elevance Health's stock is drawing attention due to its recent share move, with discussions on its valuation, strong revenue, and perceived undervaluation despite short-term pullbacks.

Elevance Health's stock contributed to Cambiar Opportunity Fund's Q2 2026 returns, benefiting from underwriting and pricing strategies that stabilized profits despite past high utilization rates.

Elevance Health is implementing new billing policies requiring hospitals to specify the physical location of care to ensure appropriate reimbursement rates for services delivered at off-campus sites.

This article highlights three defensive U.S. stocks, Elevance Health, Philip Morris International, and Altria Group, for investors seeking stability amid fluctuating interest rates and economic uncertainty.

Elevance Health, a major health benefits company, anticipates a Q3 2026 adjusted EPS decrease but has shown strong past performance and raised its full-year guidance.

Elevance Health will require hospitals to provide site-of-care information on claims to adjust reimbursement rates for off-campus services, aiming for greater affordability and transparency.

Elevance Health is implementing new billing policies in 2026-2027 to ensure accurate payments for off-campus healthcare services, aiming to lower healthcare costs and improve transparency.

Elevance Health is rolling out new billing policies to ensure services are paid at the appropriate level and drive transparency into where patients receive care, addressing inflated billing for off-campus services.

Elevance Health is changing its billing policies for site-of-care, while home health providers are using their size to grow value-based care.

Elevance Health is introducing new billing policies to prevent overcharging for services provided at off-campus locations by ensuring accurate site-of-care identification and appropriate reimbursement.

Elevance Health implemented a policy requiring accurate reporting of patient care locations to curb inflated billing by hospitals for services performed in doctor's offices.